Corton Capital’s Health Catalyst HCAT Stock Holding History

Corton Capital’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,047	Closed	-$151K	–	461
2023 Q2	$151K	Buy	+12,047	New	+$143K	0.07%	363

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Daventry Group New York $133M AUM 32.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Corton Capital's HCAT Position: Q3 2023 in Review

Corton Capital sold out of Health Catalyst (HCAT) in Q3 2023, closing a stake of 12,047 shares — an estimated $151K sold.

Corton Capital first reported a position in HCAT in Q2 2023 and held it in 1 quarter. The position peaked at $151K in Q2 2023. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2023.

Corton Capital reported no remaining Health Catalyst position as of Q3 2023 after selling out during the quarter.
Corton Capital sold 12,047 Health Catalyst shares in Q3 2023, an estimated $151K.
Corton Capital first reported a position in Health Catalyst in Q2 2023 and held it in 1 quarter.
Corton Capital's Health Catalyst position peaked at $151K in Q2 2023.
159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2023.

Based on Corton Capital's 13F filing for Q3 2023, filed 14 Nov 2023.